ISIN | LU1169820997 |
---|---|
Valor Number | 26749332 |
Bloomberg Global ID | UKCHF SW |
Fund Name | UBS (Lux) Fund Solutions - MSCI United Kingdom UCITS ETF (hedged to CHF) A-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity United Kingdom |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the price of the MSCI United Kingdom Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below. |
Peculiarities |
Current Price * | 14.88 CHF | 25.04.2025 |
---|---|---|
Previous Price * | 14.88 CHF | 24.04.2025 |
52 Week High * | 15.64 CHF | 03.03.2025 |
52 Week Low * | 13.67 CHF | 09.04.2025 |
NAV * | 14.88 CHF | 25.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 3,301,383,698 | |
Unit/Share Assets *** | 286,563,368 | |
Trading Information SIX |
YTD Performance | +3.09% |
31.12.2024 - 25.04.2025
31.12.2024 25.04.2025 |
---|---|---|
1 month | -2.78% |
25.03.2025 - 25.04.2025
25.03.2025 25.04.2025 |
3 months | -0.55% |
27.01.2025 - 25.04.2025
27.01.2025 25.04.2025 |
6 months | +1.75% |
25.10.2024 - 25.04.2025
25.10.2024 25.04.2025 |
1 year | +3.22% |
25.04.2024 - 25.04.2025
25.04.2024 25.04.2025 |
2 years | +5.67% |
25.04.2023 - 25.04.2025
25.04.2023 25.04.2025 |
3 years | +14.46% |
25.04.2022 - 25.04.2025
25.04.2022 25.04.2025 |
5 years | +44.55% |
18.06.2020 - 25.04.2025
18.06.2020 25.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.09% | |
---|---|---|
Shell PLC | 7.62% | |
HSBC Holdings PLC | 7.36% | |
Unilever PLC | 6.22% | |
RELX PLC | 3.76% | |
British American Tobacco PLC | 3.26% | |
Rolls-Royce Holdings PLC | 3.13% | |
BP PLC | 2.98% | |
GSK PLC | 2.90% | |
London Stock Exchange Group PLC | 2.85% | |
Last data update | 22.04.2025 |
TER | 0.23% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.23% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** |